Meeting
2012 ASCO Annual Meeting
Prognostic role of microRNA polymorphisms in advanced gastric cancer patients.
Authors
Linnea Stenholm
University Hospital Aachen, Aachen, Germany
Linnea Stenholm , Jan Stoehlmacher-Williams , Salah-Eddin Al-Batran , Nicole Heussen , Sema Akin , Claudia Pauligk , Sylvia Lehmann , Tina Senff , Gerhard Ehninger , Tim H. Brummendorf , Eray Goekkurt
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Tumor Biology
Track
Tumor Biology
Sub Track
Genomic and Epigenomic Biomarkers
Citation
J Clin Oncol 30, 2012 (suppl; abstr 10552)
DOI
10.1200/jco.2012.30.15_suppl.10552
Abstract #
10552
Poster Bd #
44A
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Gastrointestinal Cancers Symposium
A phase I study of FLOT as first-line treatment for advanced gastric cancer with/without severe peritoneal metastasis: Results of dose-finding part.
First Author: Kazuhiro Shiraishi
Poster
2020 ASCO Virtual Scientific Program
POF (paclitaxel/oxaliplatin/5-FU/leucovorin) versus SOX/CAPOX/FOLFOX as a postoperative adjuvant chemotherapy for curatively resected stage III gastric cancer: Study protocol for a randomized controlled trial, FNF-014 trial.
First Author: Liyu Su
Poster
2017 ASCO Annual Meeting
Perioperative trastuzumab and pertuzumab in combination with FLOT versus FLOT alone for HER2 positive resectable esophagogastric adenocarcinoma: Petrarca—A phase II trial of the German AIO.
First Author: Ralf Hofheinz
Poster
2015 Gastrointestinal Cancers Symposium
Impact of first-line fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for patients with advanced gastroesophageal adenocarcinoma: A retrospective analysis.
First Author: Aline Da Rocha Lino